PMID- 33560371
OWN - NLM
STAT- Publisher
LR  - 20210209
IS  - 1523-5866 (Electronic)
IS  - 1522-8517 (Linking)
DP  - 2021 Feb 9
TI  - A serum-based DNA methylation assay provides accurate detection of glioma.
LID - noab023 [pii]
LID - 10.1093/neuonc/noab023 [doi]
AB  - BACKGROUND: The detection of somatic mutations in cell-free DNA (cfDNA) from liquid 
      biopsy has emerged as a non-invasive tool to monitor the follow-up of cancer 
      patients. However, the significance of cfDNA clinical utility remains uncertain in 
      patients with brain tumors, primarily because of the limited sensitivity cfDNA has 
      to detect real tumor-specific somatic mutations. This unresolved challenge has 
      prevented accurate follow-up of glioma patients with non-invasive approaches. 
      METHODS: Genome-wide DNA methylation profiling of tumor tissue and serum cell-free 
      DNA of glioma patients. RESULTS: Here, we developed a non-invasive approach to 
      profile the DNA methylation status in the serum of patients with gliomas and 
      identified a cfDNA-derived methylation signature that is associated with the 
      presence of gliomas and related immune features. By testing the signature in an 
      independent discovery and validation cohorts, we developed and verified a score 
      metric (the "glioma epigenetic liquid biopsy score" or GeLB) that optimally 
      distinguished patients with or without glioma (sensitivity: 100%, specificity: 
      97.78%). Furthermore, we found that changes in GeLB score reflected 
      clinicopathological changes during surveillance (e.g., progression, 
      pseudoprogression or response to standard or experimental treatment). CONCLUSIONS: 
      Our results suggest that the GeLB score can be used as a complementary approach to 
      diagnose and follow up patients with glioma.
CI  - © The Author(s) 2021. Published by Oxford University Press on behalf of the Society 
      for Neuro-Oncology. All rights reserved. For permissions, please e-mail: 
      journals.permissions@oup.com.
FAU - Sabedot, Thais
AU  - Sabedot T
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - Malta, Tathiane
AU  - Malta T
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - Snyder, James
AU  - Snyder J
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
AD  - Department of Neuro Oncology, Henry Ford Health System, Detroit, MI, USA.
FAU - Nelson, Kevin
AU  - Nelson K
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Wells, Michael
AU  - Wells M
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - deCarvalho, Ana
AU  - deCarvalho A
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Mukherjee, Abir
AU  - Mukherjee A
AD  - Department of Pathology, Henry Ford Health System, Detroit, MI, USA.
FAU - Chitale, Dhan
AU  - Chitale D
AD  - Department of Pathology, Henry Ford Health System, Detroit, MI, USA.
FAU - Mosella, Maritza
AU  - Mosella M
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - Sokolov, Artem
AU  - Sokolov A
AD  - Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
FAU - Asmaro, Karam
AU  - Asmaro K
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - Robin, Adam
AU  - Robin A
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Rosenblum, Michael
AU  - Rosenblum M
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Mikkelsen, Tom
AU  - Mikkelsen T
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Rock, Jack
AU  - Rock J
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Poisson, Laila
AU  - Poisson L
AD  - Department of Biostatistics, Henry Ford Health System, Detroit, MI, USA.
FAU - Lee, Ian
AU  - Lee I
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Walbert, Tobias
AU  - Walbert T
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Department of Neuro Oncology, Henry Ford Health System, Detroit, MI, USA.
FAU - Kalkanis, Steven
AU  - Kalkanis S
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
FAU - Iavarone, Antonio
AU  - Iavarone A
AD  - Institute for Cancer Genetics, Department of Pathology and Cell Biology, Department 
      of Neurology, Columbia University Medical Center, New York, USA.
FAU - Castro, Ana Valeria
AU  - Castro AV
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
FAU - Noushmehr, Houtan
AU  - Noushmehr H
AD  - Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, 
      Detroit, MI, USA.
AD  - Omics Laboratory, Henry Ford Health System, Detroit, MI, USA.
LA  - eng
PT  - Journal Article
DEP - 20210209
PL  - England
TA  - Neuro Oncol
JT  - Neuro-oncology
JID - 100887420
SB  - IM
OTO - NOTNLM
OT  - cell-free DNA
OT  - epigenetics
OT  - glioma
OT  - pseudoprogression
OT  - serum
EDAT- 2021/02/10 06:00
MHDA- 2021/02/10 06:00
CRDT- 2021/02/09 12:10
PHST- 2019/04/29 00:00 [received]
PHST- 2021/02/09 12:10 [entrez]
PHST- 2021/02/10 06:00 [pubmed]
PHST- 2021/02/10 06:00 [medline]
AID - 6131768 [pii]
AID - 10.1093/neuonc/noab023 [doi]
PST - aheadofprint
SO  - Neuro Oncol. 2021 Feb 9:noab023. doi: 10.1093/neuonc/noab023.

PMID- 33558008
OWN - NLM
STAT- In-Data-Review
LR  - 20210212
IS  - 2050-084X (Electronic)
IS  - 2050-084X (Linking)
VI  - 10
DP  - 2021 Feb 9
TI  - An integrative study of five biological clocks in somatic and mental health.
LID - 10.7554/eLife.59479 [doi]
LID - e59479
AB  - Biological clocks have been developed at different molecular levels and were found 
      to be more advanced in the presence of somatic illness and mental disorders. 
      However, it is unclear whether different biological clocks reflect similar aging 
      processes and determinants. In ~3000 subjects, we examined whether five biological 
      clocks (telomere length, epigenetic, transcriptomic, proteomic, and metabolomic 
      clocks) were interrelated and associated to somatic and mental health determinants. 
      Correlations between biological aging indicators were small (all r < 0.2), 
      indicating little overlap. The most consistent associations of advanced biological 
      aging were found for male sex, higher body mass index (BMI), metabolic syndrome, 
      smoking, and depression. As compared to the individual clocks, a composite index of 
      all five clocks showed most pronounced associations with health determinants. The 
      large effect sizes of the composite index and the low correlation between biological 
      aging indicators suggest that one's biological age is best reflected by combining 
      aging measures from multiple cellular levels.
CI  - © 2021, Jansen et al.
FAU - Jansen, Rick
AU  - Jansen R
AUID- ORCID: 0000-0002-3333-6737
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 
      Public Health Research Institute and Amsterdam Neuroscience, Amsterdam, Netherlands.
FAU - Han, Laura Km
AU  - Han LK
AUID- ORCID: 0000-0001-9647-3723
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 
      Public Health Research Institute and Amsterdam Neuroscience, Amsterdam, Netherlands.
FAU - Verhoeven, Josine E
AU  - Verhoeven JE
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 
      Public Health Research Institute and Amsterdam Neuroscience, Amsterdam, Netherlands.
FAU - Aberg, Karolina A
AU  - Aberg KA
AD  - Center for Biomarker Research and Precision Medicine, Virginia Commonwealth 
      University, Richmond, United States.
FAU - van den Oord, Edwin Cgj
AU  - van den Oord EC
AD  - Center for Biomarker Research and Precision Medicine, Virginia Commonwealth 
      University, Richmond, United States.
FAU - Milaneschi, Yuri
AU  - Milaneschi Y
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 
      Public Health Research Institute and Amsterdam Neuroscience, Amsterdam, Netherlands.
FAU - Penninx, Brenda Wjh
AU  - Penninx BW
AD  - Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 
      Public Health Research Institute and Amsterdam Neuroscience, Amsterdam, Netherlands.
LA  - eng
SI  - dbGaP/phs000486.v1.p1
PT  - Journal Article
DEP - 20210209
TA  - Elife
JT  - eLife
JID - 101579614
SB  - IM
CIN - doi: 10.7554/eLife.66223
PMC - PMC7872513
OTO - NOTNLM
OT  - biological aging
OT  - cell biology
OT  - epigenetics
OT  - genetics
OT  - genomics
OT  - human
OT  - metabolomics
OT  - proteomics
OT  - telomere
OT  - transcriptomics
COIS- RJ, LH, JV, KA, Ev, YM No competing interests declared, BP has received research 
      funding (not related to the current paper) from Boehringer Ingelheim and Jansen 
      Research.
EDAT- 2021/02/10 06:00
MHDA- 2021/02/10 06:00
CRDT- 2021/02/09 05:55
PHST- 2020/05/29 00:00 [received]
PHST- 2020/12/14 00:00 [accepted]
PHST- 2021/02/09 05:55 [entrez]
PHST- 2021/02/10 06:00 [pubmed]
PHST- 2021/02/10 06:00 [medline]
AID - 59479 [pii]
AID - 10.7554/eLife.59479 [doi]
PST - epublish
SO  - Elife. 2021 Feb 9;10:e59479. doi: 10.7554/eLife.59479.

PMID- 33542217
OWN - NLM
STAT- MEDLINE
DCOM- 20210219
LR  - 20210219
IS  - 2041-1723 (Electronic)
IS  - 2041-1723 (Linking)
VI  - 12
IP  - 1
DP  - 2021 Feb 4
TI  - An all-to-all approach to the identification of sequence-specific readers for 
      epigenetic DNA modifications on cytosine.
PG  - 795
LID - 10.1038/s41467-021-20950-w [doi]
LID - 795
AB  - Epigenetic modifications of DNA play important roles in many biological processes. 
      Identifying readers of these epigenetic marks is a critical step towards 
      understanding the underlying mechanisms. Here, we present an all-to-all approach, 
      dubbed digital affinity profiling via proximity ligation (DAPPL), to simultaneously 
      profile human TF-DNA interactions using mixtures of random DNA libraries carrying 
      different epigenetic modifications (i.e., 5-methylcytosine, 5-hydroxymethylcytosine, 
      5-formylcytosine, and 5-carboxylcytosine) on CpG dinucleotides. Many proteins that 
      recognize consensus sequences carrying these modifications in symmetric and/or 
      hemi-modified forms are identified. We further demonstrate that the modifications in 
      different sequence contexts could either enhance or suppress TF binding activity. 
      Moreover, many modifications can affect TF binding specificity. Furthermore, 
      symmetric modifications show a stronger effect in either enhancing or suppressing 
      TF-DNA interactions than hemi-modifications. Finally, in vivo evidence suggests that 
      USF1 and USF2 might regulate transcription via hydroxymethylcytosine-binding 
      activity in weak enhancers in human embryonic stem cells.
FAU - Song, Guang
AU  - Song G
AUID- ORCID: 0000-0002-7630-716X
AD  - Department of Pharmacology and Molecular Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Wang, Guohua
AU  - Wang G
AUID- ORCID: 0000-0001-7381-2374
AD  - School of Computer Science and Technology, Harbin Institute of Technology, Harbin, 
      Heilongjiang, China.
FAU - Luo, Ximei
AU  - Luo X
AUID- ORCID: 0000-0003-2956-6799
AD  - School of Computer Science and Technology, Harbin Institute of Technology, Harbin, 
      Heilongjiang, China.
AD  - Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA.
FAU - Cheng, Ying
AU  - Cheng Y
AD  - Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
AD  - Institute of Biomedical Research, Yunnan University, Kunming, Yunnan, China.
FAU - Song, Qifeng
AU  - Song Q
AD  - Department of Pharmacology and Molecular Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Wan, Jun
AU  - Wan J
AUID- ORCID: 0000-0001-9286-6562
AD  - Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA.
FAU - Moore, Cedric
AU  - Moore C
AD  - Department of Pharmacology and Molecular Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA.
FAU - Song, Hongjun
AU  - Song H
AUID- ORCID: 0000-0002-8720-5310
AD  - Department of Neuroscience and Mahoney Institute for Neurosciences, University of 
      Pennsylvania, Philadelphia, PA, USA.
FAU - Jin, Peng
AU  - Jin P
AUID- ORCID: 0000-0001-6137-6659
AD  - Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
FAU - Qian, Jiang
AU  - Qian J
AUID- ORCID: 0000-0002-0476-3596
AD  - Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, 
      MD, USA. jiang.qian@jhmi.edu.
FAU - Zhu, Heng
AU  - Zhu H
AUID- ORCID: 0000-0002-8426-2889
AD  - Department of Pharmacology and Molecular Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, MD, USA. hzhu4@jhmi.edu.
LA  - eng
GR  - P01 NS097206/NS/NINDS NIH HHS/United States
GR  - R01 AG061852/AG/NIA NIH HHS/United States
GR  - R01 EY029548/EY/NEI NIH HHS/United States
GR  - R35 NS116843/NS/NINDS NIH HHS/United States
GR  - R24 AA025017/AA/NIAAA NIH HHS/United States
GR  - R01 GM111514/GM/NIGMS NIH HHS/United States
GR  - R01 EY024580/EY/NEI NIH HHS/United States
GR  - R01 MH122451/MH/NIMH NIH HHS/United States
GR  - U01 CA200469/CA/NCI NIH HHS/United States
GR  - R01 HL149961/HL/NHLBI NIH HHS/United States
GR  - T32 GM080189/GM/NIGMS NIH HHS/United States
GR  - R35 NS111602/NS/NINDS NIH HHS/United States
GR  - R01 NS051630/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210204
TA  - Nat Commun
JT  - Nature communications
JID - 101528555
RN  - 0 (Recombinant Proteins)
RN  - 0 (USF1 protein, human)
RN  - 0 (USF2 protein, human)
RN  - 0 (Upstream Stimulatory Factors)
RN  - 1123-95-1 (5-hydroxymethylcytosine)
RN  - 6R795CQT4H (5-Methylcytosine)
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - 5-Methylcytosine/*analogs & derivatives/metabolism
MH  - Cell Line
MH  - CpG Islands/genetics
MH  - DNA/genetics/*metabolism
MH  - Enhancer Elements, Genetic
MH  - Epigenesis, Genetic
MH  - Epigenomics/*methods
MH  - Gene Library
MH  - Human Embryonic Stem Cells
MH  - Humans
MH  - Recombinant Proteins/genetics/isolation & purification/metabolism
MH  - Upstream Stimulatory Factors/genetics/isolation & purification/metabolism
PMC - PMC7862700
COIS- The authors declare no competing interests.
EDAT- 2021/02/06 06:00
MHDA- 2021/02/20 06:00
CRDT- 2021/02/05 05:49
PHST- 2020/07/15 00:00 [received]
PHST- 2020/12/14 00:00 [accepted]
PHST- 2021/02/05 05:49 [entrez]
PHST- 2021/02/06 06:00 [pubmed]
PHST- 2021/02/20 06:00 [medline]
AID - 10.1038/s41467-021-20950-w [pii]
AID - 20950 [pii]
AID - 10.1038/s41467-021-20950-w [doi]
PST - epublish
SO  - Nat Commun. 2021 Feb 4;12(1):795. doi: 10.1038/s41467-021-20950-w.

PMID- 33536621
OWN - NLM
STAT- In-Process
LR  - 20210212
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 590
IP  - 7845
DP  - 2021 Feb
TI  - Regulatory genomic circuitry of human disease loci by integrative epigenomics.
PG  - 300-307
LID - 10.1038/s41586-020-03145-z [doi]
AB  - Annotating the molecular basis of human disease remains an unsolved challenge, as 
      93% of disease loci are non-coding and gene-regulatory annotations are highly 
      incomplete(1-3). Here we present EpiMap, a compendium comprising 10,000 epigenomic 
      maps across 800 samples, which we used to define chromatin states, high-resolution 
      enhancers, enhancer modules, upstream regulators and downstream target genes. We 
      used this resource to annotate 30,000 genetic loci that were associated with 
      540 traits(4), predicting trait-relevant tissues, putative causal nucleotide 
      variants in enriched tissue enhancers and candidate tissue-specific target genes for 
      each. We partitioned multifactorial traits into tissue-specific contributing factors 
      with distinct functional enrichments and disease comorbidity patterns, and revealed 
      both single-factor monotropic and multifactor pleiotropic loci. Top-scoring loci 
      frequently had multiple predicted driver variants, converging through multiple 
      enhancers with a common target gene, multiple genes in common tissues, or multiple 
      genes and multiple tissues, indicating extensive pleiotropy. Our results demonstrate 
      the importance of dense, rich, high-resolution epigenomic annotations for the 
      investigation of complex traits.
FAU - Boix, Carles A
AU  - Boix CA
AUID- ORCID: 0000-0001-9212-856X
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of 
      Technology, Cambridge, MA, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA.
AD  - Computational and Systems Biology Program, Massachusetts Institute of Technology, 
      Cambridge, MA, USA.
FAU - James, Benjamin T
AU  - James BT
AUID- ORCID: 0000-0002-6228-055X
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of 
      Technology, Cambridge, MA, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FAU - Park, Yongjin P
AU  - Park YP
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of 
      Technology, Cambridge, MA, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA.
AD  - Department of Pathology and Laboratory Medicine, University of British Columbia, 
      Vancouver, British Columbia, Canada.
FAU - Meuleman, Wouter
AU  - Meuleman W
AUID- ORCID: 0000-0002-1196-5401
AD  - Altius Institute for Biomedical Sciences, Seattle, WA, USA.
FAU - Kellis, Manolis
AU  - Kellis M
AUID- ORCID: 0000-0001-7113-9630
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of 
      Technology, Cambridge, MA, USA. manoli@mit.edu.
AD  - Broad Institute of MIT and Harvard, Cambridge, MA, USA. manoli@mit.edu.
LA  - eng
GR  - HG008155/NH/NIH HHS/United States
GR  - HG009446/NH/NIH HHS/United States
GR  - HG009088/NH/NIH HHS/United States
GR  - HG007234/NH/NIH HHS/United States
GR  - HG007610/NH/NIH HHS/United States
GR  - GM113708/NH/NIH HHS/United States
GR  - MH109978/NH/NIH HHS/United States
GR  - MH119509/NH/NIH HHS/United States
GR  - AG058002/NH/NIH HHS/United States
GR  - GM087237/NH/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210203
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
EDAT- 2021/02/05 06:00
MHDA- 2021/02/05 06:00
CRDT- 2021/02/04 05:47
PHST- 2019/10/30 00:00 [received]
PHST- 2020/12/18 00:00 [accepted]
PHST- 2021/02/05 06:00 [pubmed]
PHST- 2021/02/05 06:00 [medline]
PHST- 2021/02/04 05:47 [entrez]
AID - 10.1038/s41586-020-03145-z [pii]
AID - 10.1038/s41586-020-03145-z [doi]
PST - ppublish
SO  - Nature. 2021 Feb;590(7845):300-307. doi: 10.1038/s41586-020-03145-z. Epub 2021 Feb 
      3.

PMID- 33536596
OWN - NLM
STAT- MEDLINE
DCOM- 20210219
LR  - 20210219
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 590
IP  - 7846
DP  - 2021 Feb
TI  - An epigenetic tipping point in cancer comes under the microscope.
PG  - 399-400
LID - 10.1038/d41586-021-00002-5 [doi]
FAU - Sroka, Martyna W
AU  - Sroka MW
FAU - Vakoc, Christopher R
AU  - Vakoc CR
LA  - eng
PT  - Comment
PT  - News
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
RN  - 0 (Nucleosomes)
RN  - EC 2.1.1.- (Methyltransferases)
SB  - IM
CON - Nature. 2021 Feb;590(7846):498-503. PMID: 33361816
CON - Nature. 2021 Feb;590(7846):504-508. PMID: 33536620
MH  - Epigenesis, Genetic/genetics
MH  - Humans
MH  - Methylation
MH  - Methyltransferases
MH  - *Neoplasms/genetics
MH  - *Nucleosomes
OTO - NOTNLM
OT  - *Cancer
OT  - *Epigenetics
EDAT- 2021/02/05 06:00
MHDA- 2021/02/20 06:00
CRDT- 2021/02/04 05:47
PHST- 2021/02/05 06:00 [pubmed]
PHST- 2021/02/20 06:00 [medline]
PHST- 2021/02/04 05:47 [entrez]
AID - 10.1038/d41586-021-00002-5 [pii]
AID - 10.1038/d41586-021-00002-5 [doi]
PST - ppublish
SO  - Nature. 2021 Feb;590(7846):399-400. doi: 10.1038/d41586-021-00002-5.

PMID- 33523105
OWN - NLM
STAT- Publisher
LR  - 20210212
IS  - 2168-6157 (Electronic)
IS  - 2168-6149 (Print)
IS  - 2168-6149 (Linking)
DP  - 2021 Feb 1
TI  - Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide 
      Association Study, Expression, and Epigenetic Data Sets.
LID - 10.1001/jamaneurol.2020.5257 [doi]
LID - e205257
AB  - IMPORTANCE: Substantial genome-wide association study (GWAS) work in Parkinson 
      disease (PD) has led to the discovery of an increasing number of loci shown reliably 
      to be associated with increased risk of disease. Improved understanding of the 
      underlying genes and mechanisms at these loci will be key to understanding the 
      pathogenesis of PD. OBJECTIVE: To investigate what genes and genomic processes 
      underlie the risk of sporadic PD. DESIGN AND SETTING: This genetic association study 
      used the bioinformatic tools Coloc and transcriptome-wide association study (TWAS) 
      to integrate PD case-control GWAS data published in 2017 with expression data (from 
      Braineac, the Genotype-Tissue Expression [GTEx], and CommonMind) and methylation 
      data (derived from UK Parkinson brain samples) to uncover putative gene expression 
      and splicing mechanisms associated with PD GWAS signals. Candidate genes were 
      further characterized using cell-type specificity, weighted gene coexpression 
      networks, and weighted protein-protein interaction networks. MAIN OUTCOMES AND 
      MEASURES: It was hypothesized a priori that some genes underlying PD loci would 
      alter PD risk through changes to expression, splicing, or methylation. Candidate 
      genes are presented whose change in expression, splicing, or methylation are 
      associated with risk of PD as well as the functional pathways and cell types in 
      which these genes have an important role. RESULTS: Gene-level analysis of expression 
      revealed 5 genes (WDR6 [OMIM 606031], CD38 [OMIM 107270], GPNMB [OMIM 604368], RAB29 
      [OMIM 603949], and TMEM163 [OMIM 618978]) that replicated using both Coloc and TWAS 
      analyses in both the GTEx and Braineac expression data sets. A further 6 genes 
      (ZRANB3 [OMIM 615655], PCGF3 [OMIM 617543], NEK1 [OMIM 604588], NUPL2 [NCBI 11097], 
      GALC [OMIM 606890], and CTSB [OMIM 116810]) showed evidence of disease-associated 
      splicing effects. Cell-type specificity analysis revealed that gene expression was 
      overall more prevalent in glial cell types compared with neurons. The weighted gene 
      coexpression performed on the GTEx data set showed that NUPL2 is a key gene in 3 
      modules implicated in catabolic processes associated with protein ubiquitination and 
      in the ubiquitin-dependent protein catabolic process in the nucleus accumbens, 
      caudate, and putamen. TMEM163 and ZRANB3 were both important in modules in the 
      frontal cortex and caudate, respectively, indicating regulation of signaling and 
      cell communication. Protein interactor analysis and simulations using random 
      networks demonstrated that the candidate genes interact significantly more with 
      known mendelian PD and parkinsonism proteins than would be expected by chance. 
      CONCLUSIONS AND RELEVANCE: Together, these results suggest that several candidate 
      genes and pathways are associated with the findings observed in PD GWAS studies.
FAU - Kia, Demis A
AU  - Kia DA
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Zhang, David
AU  - Zhang D
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Guelfi, Sebastian
AU  - Guelfi S
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Manzoni, Claudia
AU  - Manzoni C
AD  - Department of Pharmacology, School of Pharmacy, University College London, London, 
      United Kingdom.
FAU - Hubbard, Leon
AU  - Hubbard L
AD  - Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, 
      University of Cardiff, Cardiff, United Kingdom.
FAU - Reynolds, Regina H
AU  - Reynolds RH
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Botía, Juan
AU  - Botía J
AD  - Departamento de Ingeniería de la Información y las Comunicaciones, Universidad de 
      Murcia, Murcia, Spain.
FAU - Ryten, Mina
AU  - Ryten M
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Ferrari, Raffaele
AU  - Ferrari R
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
FAU - Lewis, Patrick A
AU  - Lewis PA
AD  - Department of Comparative Biomedical Sciences, The Royal Veterinary College, London, 
      United Kingdom.
AD  - School of Pharmacy, University of Reading, Reading, United Kingdom.
FAU - Williams, Nigel
AU  - Williams N
AD  - Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, 
      University of Cardiff, Cardiff, United Kingdom.
FAU - Trabzuni, Daniah
AU  - Trabzuni D
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
AD  - Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, 
      Saudi Arabia.
FAU - Hardy, John
AU  - Hardy J
AD  - Department of Neurodegenerative Disease and Reta Lila Weston Laboratories, 
      University College London Dementia Research Institute, London, United Kingdom.
FAU - Wood, Nicholas W
AU  - Wood NW
AD  - Department of Molecular Neuroscience, University College London Institute of 
      Neurology, Queen Square, London, United Kingdom.
CN  - United Kingdom Brain Expression Consortium (UKBEC) and the International Parkinson’s 
      Disease Genomics Consortium (IPDGC)
LA  - eng
GR  - G-1309/PUK_/Parkinson's UK/United Kingdom
GR  - G-1502/PUK_/Parkinson's UK/United Kingdom
PT  - Journal Article
DEP - 20210201
TA  - JAMA Neurol
JT  - JAMA neurology
JID - 101589536
SB  - AIM
SB  - IM
PMC - PMC7851759
COIS- Conflict of Interest Disclosures: Dr Manzoni and Dr Lewis reported receiving grants 
      from Medical Research Council (MRC) during the conduct of the study. Dr Williams 
      reported receiving grants from Parkinson’s UK during the conduct of the study. Dr 
      Trabzuni reported receiving personal fees from King Faisal Specialist Hospital 
      during the conduct of the study; and grants from University College London outside 
      the submitted work. No other disclosures were reported.
FIR - Noyce, Alastair J
IR  - Noyce AJ
FIR - Kaiyrzhanov, Rauan
IR  - Kaiyrzhanov R
FIR - Middlehurst, Ben
IR  - Middlehurst B
FIR - Kia, Demis A
IR  - Kia DA
FIR - Tan, Manuela
IR  - Tan M
FIR - Houlden, Henry
IR  - Houlden H
FIR - Morris, Huw R
IR  - Morris HR
FIR - Plun-Favreau, Helene
IR  - Plun-Favreau H
FIR - Holmans, Peter
IR  - Holmans P
FIR - Hardy, John
IR  - Hardy J
FIR - Trabzuni, Daniah
IR  - Trabzuni D
FIR - Bras, Jose
IR  - Bras J
FIR - PhD, John Quinn
IR  - PhD JQ
FIR - Mok, Kin Y
IR  - Mok KY
FIR - Kinghorn, Kerri J
IR  - Kinghorn KJ
FIR - Billingsley, Kimberley
IR  - Billingsley K
FIR - Wood, Nicholas W
IR  - Wood NW
FIR - Lewis, Patrick
IR  - Lewis P
FIR - Schreglmann, Sebastian
IR  - Schreglmann S
FIR - Guerreiro, Rita
IR  - Guerreiro R
FIR - Lovering, Ruth
IR  - Lovering R
FIR - R'Bibo, Lea
IR  - R'Bibo L
FIR - Manzoni, Claudia
IR  - Manzoni C
FIR - Rizig, Mie
IR  - Rizig M
FIR - Ryten, Mina
IR  - Ryten M
FIR - Guelfi, Sebastian
IR  - Guelfi S
FIR - Escott-Price, Valentina
IR  - Escott-Price V
FIR - Chelban, Viorica
IR  - Chelban V
FIR - Foltynie, Thomas
IR  - Foltynie T
FIR - Williams, Nigel
IR  - Williams N
FIR - Brice, Alexis
IR  - Brice A
FIR - Danjou, Fabrice
IR  - Danjou F
FIR - Lesage, Suzanne
IR  - Lesage S
FIR - Corvol, Jean-Christophe
IR  - Corvol JC
FIR - Martinez, Maria
IR  - Martinez M
FIR - Schulte, Claudia
IR  - Schulte C
FIR - Brockmann, Kathrin
IR  - Brockmann K
FIR - Simón-Sánchez, Javier
IR  - Simón-Sánchez J
FIR - Heutink, Peter
IR  - Heutink P
FIR - Rizzu, Patrizia
IR  - Rizzu P
FIR - Sharma, Manu
IR  - Sharma M
FIR - Gasser, Thomas
IR  - Gasser T
FIR - Nicolas, Aude
IR  - Nicolas A
FIR - Cookson, Mark R
IR  - Cookson MR
FIR - Bandres-Ciga, Sara
IR  - Bandres-Ciga S
FIR - Blauwendraat, Cornelis
IR  - Blauwendraat C
FIR - Craig, David W
IR  - Craig DW
FIR - Faghri, Faraz
IR  - Faghri F
FIR - Gibbs, J Raphael
IR  - Gibbs JR
FIR - Hernandez, Dena G
IR  - Hernandez DG
FIR - Van Keuren-Jensen, Kendall
IR  - Van Keuren-Jensen K
FIR - Shulman, Joshua M
IR  - Shulman JM
FIR - Leonard, Hampton L
IR  - Leonard HL
FIR - Nalls, Mike A
IR  - Nalls MA
FIR - Robak, Laurie
IR  - Robak L
FIR - Lubbe, Steven
IR  - Lubbe S
FIR - Finkbeiner, Steven
IR  - Finkbeiner S
FIR - Mencacci, Niccolo E
IR  - Mencacci NE
FIR - Lungu, Codrin
IR  - Lungu C
FIR - Singleton, Andrew B
IR  - Singleton AB
FIR - Scholz, Sonja W
IR  - Scholz SW
FIR - Reed, Xylena
IR  - Reed X
FIR - Alcalay, Roy N
IR  - Alcalay RN
FIR - Gan-Or, Ziv
IR  - Gan-Or Z
FIR - Rouleau, Guy A
IR  - Rouleau GA
FIR - Krohn, Lynne
IR  - Krohn L
FIR - van Hilten, Jacobus J
IR  - van Hilten JJ
FIR - Marinus, Johan
IR  - Marinus J
FIR - Adarmes-Gómez, Astrid D
IR  - Adarmes-Gómez AD
FIR - Aguilar, Miquel
IR  - Aguilar M
FIR - Alvarez, Ignacio
IR  - Alvarez I
FIR - Alvarez, Victoria
IR  - Alvarez V
FIR - Javier Barrero, Francisco
IR  - Javier Barrero F
FIR - Bergareche Yarza, Jesús A
IR  - Bergareche Yarza JA
FIR - Bernal-Bernal, Inmaculada
IR  - Bernal-Bernal I
FIR - Blazquez, Marta
IR  - Blazquez M
FIR - Bonilla-Toribio, Marta
IR  - Bonilla-Toribio M
FIR - Botía, Juan A
IR  - Botía JA
FIR - Boungiorno, María T
IR  - Boungiorno MT
FIR - Buiza-Rueda, Dolores
IR  - Buiza-Rueda D
FIR - Càmara, Ana
IR  - Càmara A
FIR - Carrillo, Fátima
IR  - Carrillo F
FIR - Carrión-Claro, Mario
IR  - Carrión-Claro M
FIR - Cerdan, Debora
IR  - Cerdan D
FIR - Clarimón, Jordi
IR  - Clarimón J
FIR - Compta, Yaroslau
IR  - Compta Y
FIR - Diez-Fairen, Monica
IR  - Diez-Fairen M
FIR - Dols-Icardo, Oriol
IR  - Dols-Icardo O
FIR - Duarte, Jacinto
IR  - Duarte J
FIR - Duran, Raquel
IR  - Duran R
FIR - Escamilla-Sevilla, Francisco
IR  - Escamilla-Sevilla F
FIR - Ezquerra, Mario
IR  - Ezquerra M
FIR - Feliz, Cici
IR  - Feliz C
FIR - Fernàndez, Manel
IR  - Fernàndez M
FIR - Fernàndez-Santiago, Rubén
IR  - Fernàndez-Santiago R
FIR - Garcia, Ciara
IR  - Garcia C
FIR - García-Ruiz, Pedro
IR  - García-Ruiz P
FIR - Gómez-Garre, Pilar
IR  - Gómez-Garre P
FIR - Gomez Heredia, Maria J
IR  - Gomez Heredia MJ
FIR - Gonzalez-Aramburu, Isabel
IR  - Gonzalez-Aramburu I
FIR - Pagola, Ana G
IR  - Pagola AG
FIR - Hoenicka, Janet
IR  - Hoenicka J
FIR - Infante, Jon
IR  - Infante J
FIR - Jimenez-Escrig, Adriano
IR  - Jimenez-Escrig A
FIR - Kulisevsky, Jaime
IR  - Kulisevsky J
FIR - Labrador-Espinosa, Miguel A
IR  - Labrador-Espinosa MA
FIR - Lopez-Sendon, Jose Luis
IR  - Lopez-Sendon JL
FIR - Arregui, Adolfo López de Munain
IR  - Arregui ALM
FIR - Macias, Daniel
IR  - Macias D
FIR - Torres, Irene Martínez
IR  - Torres IM
FIR - Marín, Juan
IR  - Marín J
FIR - Marti, Maria Jose
IR  - Marti MJ
FIR - Martínez-Castrillo, Juan Carlos
IR  - Martínez-Castrillo JC
FIR - Mèndez-Del-Barrio, Carlota
IR  - Mèndez-Del-Barrio C
FIR - González, Manuel Menéndez
IR  - González MM
FIR - Adolfo Mínguez, Marina Mata
IR  - Adolfo Mínguez MM
FIR - Mir, Pablo
IR  - Mir P
FIR - Rezola, Elisabet Mondragon
IR  - Rezola EM
FIR - Muñoz, Esteban
IR  - Muñoz E
FIR - Pagonabarraga, Javier
IR  - Pagonabarraga J
FIR - Pastor, Pau
IR  - Pastor P
FIR - Errazquin, Francisco Perez
IR  - Errazquin FP
FIR - Perińán-Tocino, Teresa
IR  - Perińán-Tocino T
FIR - Ruiz-Martínez, Javier
IR  - Ruiz-Martínez J
FIR - Ruz, Clara
IR  - Ruz C
FIR - Rodriguez, Antonio Sanchez
IR  - Rodriguez AS
FIR - Sierra, María
IR  - Sierra M
FIR - Suarez-Sanmartin, Esther
IR  - Suarez-Sanmartin E
FIR - Tabernero, Cesar
IR  - Tabernero C
FIR - Tartari, Juan Pablo
IR  - Tartari JP
FIR - Tejera-Parrado, Cristina
IR  - Tejera-Parrado C
FIR - Tolosa, Eduard
IR  - Tolosa E
FIR - Valldeoriola, Francesc
IR  - Valldeoriola F
FIR - Vargas-González, Laura
IR  - Vargas-González L
FIR - Vela, Lydia
IR  - Vela L
FIR - Vives, Francisco
IR  - Vives F
FIR - Zimprich, Alexander
IR  - Zimprich A
FIR - Pihlstrom, Lasse
IR  - Pihlstrom L
FIR - Toft, Mathias
IR  - Toft M
FIR - Koks, Sulev
IR  - Koks S
FIR - Taba, Pille
IR  - Taba P
FIR - Hassin-Baer, Sharon
IR  - Hassin-Baer S
FIR - Weale, Michael
IR  - Weale M
FIR - Ramasamy, Adaikalavan
IR  - Ramasamy A
FIR - Smith, Colin
IR  - Smith C
FIR - Guelfi, Manuel Sebastian
IR  - Guelfi MS
FIR - D'sa, Karishma
IR  - D'sa K
FIR - Forabosco, Paola
IR  - Forabosco P
FIR - Botiá, Juan A
IR  - Botiá JA
EDAT- 2021/02/02 06:00
MHDA- 2021/02/02 06:00
CRDT- 2021/02/01 12:18
PHST- 2021/02/01 12:18 [entrez]
PHST- 2021/02/02 06:00 [pubmed]
PHST- 2021/02/02 06:00 [medline]
AID - 2775977 [pii]
AID - noi200099 [pii]
AID - 10.1001/jamaneurol.2020.5257 [doi]
PST - aheadofprint
SO  - JAMA Neurol. 2021 Feb 1:e205257. doi: 10.1001/jamaneurol.2020.5257.

PMID- 33505025
OWN - NLM
STAT- Publisher
LR  - 20210219
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2021 Jan 27
TI  - Systematic analysis of binding of transcription factors to noncoding variants.
LID - 10.1038/s41586-021-03211-0 [doi]
AB  - Many sequence variants have been linked to complex human traits and diseases(1), but 
      deciphering their biological functions remains challenging, as most of them reside 
      in noncoding DNA. Here we have systematically assessed the binding of 270 human 
      transcription factors to 95,886 noncoding variants in the human genome using an 
      ultra-high-throughput multiplex protein-DNA binding assay, termed single-nucleotide 
      polymorphism evaluation by systematic evolution of ligands by exponential enrichment 
      (SNP-SELEX). The resulting 828 million measurements of transcription factor-DNA 
      interactions enable estimation of the relative affinity of these transcription 
      factors to each variant in vitro and evaluation of the current methods to predict 
      the effects of noncoding variants on transcription factor binding. We show that the 
      position weight matrices of most transcription factors lack sufficient predictive 
      power, whereas the support vector machine combined with the gapped k-mer 
      representation show much improved performance, when assessed on results from 
      independent SNP-SELEX experiments involving a new set of 61,020 sequence variants. 
      We report highly predictive models for 94 human transcription factors and 
      demonstrate their utility in genome-wide association studies and understanding of 
      the molecular pathways involved in diverse human traits and diseases.
FAU - Yan, Jian
AU  - Yan J
AUID- ORCID: 0000-0002-1267-2870
AD  - School of Medicine, Northwest University, Xi'an, China. jian.yan@cityu.edu.hk.
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA. jian.yan@cityu.edu.hk.
AD  - Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, 
      China. jian.yan@cityu.edu.hk.
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, 
      Sweden. jian.yan@cityu.edu.hk.
FAU - Qiu, Yunjiang
AU  - Qiu Y
AUID- ORCID: 0000-0002-0539-9714
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA.
AD  - Bioinformatics and Systems Biology Graduate Program, University of California San 
      Diego, La Jolla, CA, USA.
FAU - Ribeiro Dos Santos, André M
AU  - Ribeiro Dos Santos AM
AUID- ORCID: 0000-0002-7005-3576
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA.
AD  - Universidade Federal do Pará, Institute of Biological Sciences, Belém, Brazil.
FAU - Yin, Yimeng
AU  - Yin Y
AUID- ORCID: 0000-0002-5454-608X
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, 
      Sweden.
AD  - Department of Biochemistry, University of Cambridge, Cambridge, UK.
FAU - Li, Yang E
AU  - Li YE
AUID- ORCID: 0000-0001-6997-6018
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA.
AD  - Department of Cellular and Molecular Medicine, University of California San Diego, 
      La Jolla, CA, USA.
FAU - Vinckier, Nick
AU  - Vinckier N
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Nariai, Naoki
AU  - Nariai N
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Benaglio, Paola
AU  - Benaglio P
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Raman, Anugraha
AU  - Raman A
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA.
AD  - Bioinformatics and Systems Biology Graduate Program, University of California San 
      Diego, La Jolla, CA, USA.
FAU - Li, Xiaoyu
AU  - Li X
AD  - School of Medicine, Northwest University, Xi'an, China.
AD  - Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, 
      China.
FAU - Fan, Shicai
AU  - Fan S
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Chiou, Joshua
AU  - Chiou J
AUID- ORCID: 0000-0002-4618-0647
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Chen, Fulin
AU  - Chen F
AD  - School of Medicine, Northwest University, Xi'an, China.
FAU - Frazer, Kelly A
AU  - Frazer KA
AUID- ORCID: 0000-0002-6060-8902
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Gaulton, Kyle J
AU  - Gaulton KJ
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Sander, Maike
AU  - Sander M
AUID- ORCID: 0000-0001-5308-7785
AD  - Department of Cellular and Molecular Medicine, University of California San Diego, 
      La Jolla, CA, USA.
AD  - Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
FAU - Taipale, Jussi
AU  - Taipale J
AUID- ORCID: 0000-0003-4204-0951
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, 
      Sweden. ajt208@cam.ac.uk.
AD  - Department of Biochemistry, University of Cambridge, Cambridge, UK. 
      ajt208@cam.ac.uk.
AD  - Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland. 
      ajt208@cam.ac.uk.
FAU - Ren, Bing
AU  - Ren B
AUID- ORCID: 0000-0002-5435-1127
AD  - Ludwig Institute for Cancer Research, La Jolla, CA, USA. biren@ucsd.edu.
AD  - Department of Cellular and Molecular Medicine, University of California San Diego, 
      La Jolla, CA, USA. biren@ucsd.edu.
AD  - Center for Epigenomics, University of California San Diego, La Jolla, CA, USA. 
      biren@ucsd.edu.
LA  - eng
PT  - Journal Article
DEP - 20210127
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
EDAT- 2021/01/29 06:00
MHDA- 2021/01/29 06:00
CRDT- 2021/01/28 05:40
PHST- 2018/11/28 00:00 [received]
PHST- 2020/12/11 00:00 [accepted]
PHST- 2021/01/29 06:00 [pubmed]
PHST- 2021/01/29 06:00 [medline]
PHST- 2021/01/28 05:40 [entrez]
AID - 10.1038/s41586-021-03211-0 [pii]
AID - 10.1038/s41586-021-03211-0 [doi]
PST - aheadofprint
SO  - Nature. 2021 Jan 27. doi: 10.1038/s41586-021-03211-0.
